Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Price

Showing results (211-220 of 500) with videos related to

Pageof 50
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 2008
TCR beta-chain sharing in human CD8+ T cell responses to cytomegalovirus and EBVVanessa Venturi, Hui Yee Chin, Tedi E Asher, et al.
Hepatology (Baltimore, Md.)|September 5, 2013
Immunodominance and functional alterations of tumor-associated antigen-specific CD8+ T-cell responses in hepatocellular carcinomaTobias Flecken, Nathalie Schmidt, Sandra Hild, et al.
Plos Computational Biology|June 20, 2014
Quantification of HTLV-1 clonality and TCR diversityDaniel J Laydon, Anat Melamed, Aaron Sim, et al.
International Journal of Cancer|October 22, 2013
Progression of carcinogen-induced fibrosarcomas is associated with the accumulation of naïve CD4+ T cells via blood vessels and lymphaticsBeatrice Ondondo, Emma Jones, James Hindley, et al.
The Journal of Experimental Medicine|December 13, 2006
Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturationJoseph P Casazza, Michael R Betts, David A Price, et al.
The Journal of Biological Chemistry|November 9, 2004
Design of soluble recombinant T cell receptors for antigen targeting and T cell inhibitionBruno Laugel, Jonathan M Boulter, Nikolai Lissin, et al.
JCI Insight|June 17, 2024
Immunotoxin-mediated depletion of Gag-specific CD8+ T cells undermines natural control of SIVJennifer Simpson, Carly E Starke, Alexandra M Ortiz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2005
CD8+ T cell epitope-flanking mutations disrupt proteasomal processing of HIV-1 NefAnita Milicic, David A Price, Peter Zimbwa, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 9, 2002
Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infectionAnnette Oxenius, David A Price, Huldrych F Günthard, et al.
The Journal of Infectious Diseases|March 20, 2004
HIV-specific cellular immune response is inversely correlated with disease progression as defined by decline of CD4+ T cells in relation to HIV RNA loadAnnette Oxenius, David A Price, Martin Hersberger, et al.
Pageof 50

Showing results (211-220 of 500) with videos related to

Sort By:
Pageof 50
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 2008
TCR beta-chain sharing in human CD8+ T cell responses to cytomegalovirus and EBVVanessa Venturi, Hui Yee Chin, Tedi E Asher, et al.
Hepatology (Baltimore, Md.)|September 5, 2013
Immunodominance and functional alterations of tumor-associated antigen-specific CD8+ T-cell responses in hepatocellular carcinomaTobias Flecken, Nathalie Schmidt, Sandra Hild, et al.
Plos Computational Biology|June 20, 2014
Quantification of HTLV-1 clonality and TCR diversityDaniel J Laydon, Anat Melamed, Aaron Sim, et al.
International Journal of Cancer|October 22, 2013
Progression of carcinogen-induced fibrosarcomas is associated with the accumulation of naïve CD4+ T cells via blood vessels and lymphaticsBeatrice Ondondo, Emma Jones, James Hindley, et al.
The Journal of Experimental Medicine|December 13, 2006
Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturationJoseph P Casazza, Michael R Betts, David A Price, et al.
The Journal of Biological Chemistry|November 9, 2004
Design of soluble recombinant T cell receptors for antigen targeting and T cell inhibitionBruno Laugel, Jonathan M Boulter, Nikolai Lissin, et al.
JCI Insight|June 17, 2024
Immunotoxin-mediated depletion of Gag-specific CD8+ T cells undermines natural control of SIVJennifer Simpson, Carly E Starke, Alexandra M Ortiz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2005
CD8+ T cell epitope-flanking mutations disrupt proteasomal processing of HIV-1 NefAnita Milicic, David A Price, Peter Zimbwa, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 9, 2002
Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infectionAnnette Oxenius, David A Price, Huldrych F Günthard, et al.
The Journal of Infectious Diseases|March 20, 2004
HIV-specific cellular immune response is inversely correlated with disease progression as defined by decline of CD4+ T cells in relation to HIV RNA loadAnnette Oxenius, David A Price, Martin Hersberger, et al.
Pageof 50